Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite ...
Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal
Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced ...
Yahoo Finance2d
ELI LILLY AND COMPANY (LLYCL.SN)
Several other top trending stocks on the Yahoo Finance platform include Paramount Global (PARA) as the media company agrees to an $8 billion merger with Skydance Media; Eli Lilly (LLY) $3.2 ...
In-Depth Analysis: Eli Lilly and Co Versus Competitors In Pharmaceuticals Industry
Compared to its industry, the company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of ...
Eli Lilly to Buy Morphic Holding for $3.2 Billion
Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the ...
Nasdaq6d
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Eli Lilly (LLY) has recently been on ... While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate ...
Analyst revamps Eli Lilly stock price target ahead of Q2 earnings
Eli Lilly, with a market value of nearly $900 billion, has vaulted past Tesla into the top 10 list of U.S. companies.
Forbes3d
Pfizer Vs. Eli Lilly Stock – Which Is A Better Pick?
Pfizer is also benefiting from its Seagen acquisition, which is expected to add $10 billion to the company’s top-line by ...
Eli Lilly to buy biopharma company Morphic in $3.2 billion deal
The acquisition bolsters Lilly's gastroenterology portfolio, with a focus on developing new treatments for inflammatory bowel ...
Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
Pharmaceutical giant Eli Lilly (NYSE: LLY) has gotten off to an incredible start in 2024.